METHADONE , Suboxone 2 mg/0.5 mg sublingual tablets
Approved small_molecule active
Quick answer
METHADONE , Suboxone 2 mg/0.5 mg sublingual tablets for Opioid use disorder (DSM-5); chronic non-cancer pain (ICD-11). is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Opioid use disorder (DSM-5); chronic non-cancer pain (ICD-11).
- Phase
- Approved
- Modality
- small_molecule
- Status
- active